CIVSDNA• 28 Days (Normalized)
CI vs DNA (The Cigna Group vs Ginkgo Bioworks Holdings Inc.)
Showing Closing Date Range from Sep 10 to Oct 8, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CI Performance $281.03
+0.04%
The Cigna Group
Normalized Baseline0.00%
DNA Performance $11.35
+67.33%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
-67.29 pts
DNA outperforming by 67.29 percentage points
CIDNA
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CI DNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(21 dates)
| Date | CI Price | CI Gain (%) | DNA Price | DNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 08, 2026 | $281.03 | +0.04% | $11.35 | +67.33% | -67.29% |
| Oct 07, 2026 | $278.51 | -0.85% | $11.47 | +69.17% | -70.02% |
| Oct 06, 2026 | $274.37 | -2.33% | $12.41 | +83.04% | -85.37% |
| Oct 05, 2026 | $271.29 | -3.42% | $14.98 | +120.94% | -124.36% |
| Oct 02, 2026 | $270.53 | -3.70% | $12.35 | +82.15% | -85.85% |
| Oct 01, 2026 | $267.96 | -4.61% | $12.50 | +84.37% | -88.98% |
| Sep 30, 2026 | $271.83 | -3.23% | $12.83 | +89.23% | -92.46% |
| Sep 29, 2026 | $275.26 | -2.01% | $11.96 | +76.40% | -78.41% |
| Sep 28, 2026 | $- | $10.46 | +54.28% | - | |
| Sep 25, 2026 | $- | $10.66 | +57.23% | - | |
| Sep 24, 2026 | $265.50 | -5.49% | $10.25 | +51.18% | -56.67% |
| Sep 23, 2026 | $268.27 | -4.50% | $8.58 | +26.55% | -31.05% |
| Sep 22, 2026 | $273.74 | -2.55% | $9.37 | +38.20% | -40.75% |
| Sep 21, 2026 | $274.47 | -2.29% | $7.98 | +17.70% | -19.99% |
| Sep 18, 2026 | $275.28 | -2.00% | $7.88 | +16.22% | -18.22% |
Page 1 of 2